型号:
产品价格:电议      采购度:1601      原产地:美洲
发布时间:2021/7/25 9:06:03 所属地区:上海 上海市
简要描述:
M2698 (MSC2363318A) 是一种具有口服活性,ATP 竞争的,选择性的 p70S6K 和 Akt 双重抑制剂,对于 p70S6K,Akt1 和 Akt3 的 IC50 均为 1 nM。M2698 可以透过血脑屏障,具有抗癌活性。
标签:MSC2363318A
产品详情
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
CAS No. : 1379545-95-5
MCE 站:M2698
产品活性:M2698 (MSC2363318A) 是一种具有口服活性,ATP 竞争的,选择性的 p70S6K 和 Akt 双重抑制剂,对于 p70S6K,Akt1 和 Akt3 的 IC50 均为 1 nM。M2698 可以透过血脑屏障,具有抗癌活性。
研究领域:MAPK/ERK Pathway | PI3K/Akt/mTOR
作用靶点:Ribosomal S6 Kinase (RSK) | Akt
In Vitro: M2698 (0.3 nM to 50 M; 72 hours) inhibits proliferation in a dose-dependent manner in breast tumors cell lines with IC50s of 0.02-8.5 ?M.
M2698 (0.3, 1 ?M; 24 hours) inhibits p70S6K activity and induces feedback loop phosphorylation on Akt and suppresses Akt activity in breast cancer cell lines.
M2698 inhibits indirectly pGSK3β (IC50=17 nM) and pS6 (IC50=15 nM).
In Vivo: M2698 (10-30 mg/kg/day; PO; 28 days) results in dose-dependent inhibition of tumor growth and results in tumor regression with the highest dose of 30 mg/kg.
M2698 (20 mg/kg/day; PO; 4 days) has a tumor:plasma exposure ratio of 12:1 over 24 hours and leads to increased levels of pAkt in tumor tissue.
The mean total concentration of M2698 after 16-hour infusion in rats is 1750 ng/g and 175 ng/mL in brain and plasma, respectively.
M2698 (po; 1, 5, 10, or 20 mg/kg/day; for 7 days) inhibits the phosphorylation of S6 in a dose-proportional manner over time after a single administration or daily treatments over 7 days.
相关产品:Bioactive Compound Library Plus | Immunology/Inflammation Compound Library | Kinase Inhibitor Library | MAPK Compound Library | PI3K/Akt/mTOR Compound Library | Stem Cell Signaling Compound Library | Anti-Cancer Compound Library | Autophagy Compound Library | Anti-Aging Compound Library | Differentiation Inducing Compound Library | Reprogramming Compound Library | Oxygen Sensing Compound Library | Glycolysis Compound Library | Cytoskeleton Compound Library | Glutamine Metabolism Compound Library | Anti-Breast Cancer Compound Library | Anti-Lung Cancer Compound Library | Anti-Pancreatic Cancer Compound Library | Anti-Blood Cancer Compound Library | Honokiol | GSK-690693 | Artemisinin | PF-4708671 | Oridonin | Perifosine | Guggulsterone | Miransertib | Triciribine | Recilisib | SU6656 | Isobavachalcone | Scutellarin | Deguelin | Miltefosine | A-674563 hydrochloride | Carnosol | Pluripotin | α-Linolenic acid | YS-49 | LJH685 | Urolithin B | Polyphyllin I | Sodium Salicylate | Pachymic acid | 3CAI | LJI308 | Quercitrin | 1,3-Dicaffeoylquinic acid
品牌介绍:
• MCE (MedChemExpress) 拥有数百种全球独家化合物,我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物;
• 10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域;
• 设有专业的实验中心和严格的质控、验证体系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告,确保产品的高纯度、高品质;
• 产品的生物活性多经各国客户实验验证;
• Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果;
• 专业团队跟踪*新的制药及生命科学研究进展,为您提供全球*新的活性化合物;
• 与世界各大制药公司及知名科研机构建立了长期的合作。
更新时间:2024/1/2 10:15:43
留言咨询
温馨提示
1.遵守中华人民共和国有关法律、法规,尊重网上道德,承担一切因您的行为而直接或间接引起的法律责任。
2.请您真实的反映产品的情况,不要捏造、诬蔑、造谣。如对产品有任何疑问,也可以留言咨询。
3.未经本站同意,任何人不得利用本留言簿发布个人或团体的具有广告性质的信息或类似言论。
相关新闻
相关产品